Results of KEYNOTE-054; melanoma patients treated with pembrolizumab.

Results from CheckMate-227 : Immune combination reaches PFS endpoint

Editor's Choice for February 2018

Tumour fraction in circulating free DNA as a biomarker of disease dynamics in metastatic prostate cancer

Immunotherapy and targeted treatments in breast cancer reviewed

The best sequence of anti-HER2 therapy in metastatic breast cancer

ESO-ESMO-ABC guidelines in metastatic breast cancer

BGICC conference highlights: Changing standards in breast and gynaecological cancers

Management of inflammatory breast cancer

Different treatment strategies for BRCA positive breast cancer

Neoadjuvant and adjuvant therapy in triple negative breast cancer

The DESKTOPIII trial in platinum-sensitive ovarian cancer